Genmab A/S (GE91) Short Interest
DB • GE91 • US3723032062
As of Oct 20, 2026, ORTEX estimated 0.2% of free float sold short, 4,092.1 days to cover, cost to borrow 0.86%. Sign up for live short interest data.
DB • GE91 • US3723032062
As of Oct 20, 2026, ORTEX estimated 0.2% of free float sold short, 4,092.1 days to cover, cost to borrow 0.86%. Sign up for live short interest data.
This page tracks how heavily Genmab A/S (DB:GE91) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Genmab A/S (DB: GE91) has a market capitalization of $32.02B. Last close €49.20 (as of 2026-11-05); 52-week range €20.20 to €51.50. ORTEX data as of 2026-10-20: short interest was 0.16% of free float, 4,092.1 days to cover and the average cost to borrow was 0.86%. Sign up for live short interest data.